BMRA
BIOMERICA INC
Saved in this browser
Ready 8-Ks
3
Latest filing
Dec 16, 2025 23:59 UTC
Top materiality
0.55
Event mix
leadership ×2 · other_material ×1
Sentiment
1 pos · 0 neg · 2 neu
Recent 8-K filings for BMRA
Highest-materiality recent filing
Oct 08, 2025 23:59 UTC
leadership
materiality 0.55
positive
item 5.02item 7.01item 9.01
- Gary Huff appointed as independent director effective Oct 7, 2025; will serve on Audit, Comp, and Governance committees.
- Huff receives annualized cash fee of $45,000 (paid quarterly); no equity compensation granted for board appointment.
Read filing →
-
Dec 16, 2025 23:59 UTC
other_material
materiality 0.40
neutral
item 5.07
Biomerica stockholders elect all 5 director nominees, approve share increase from 25M to 300M at 2025 annual meeting
All five director nominees elected with majority votes: Irani, Barbieri, Bing Chin, Huff, Moatazedi.
-
Oct 08, 2025 23:59 UTC
leadership
materiality 0.55
positive
item 5.02item 7.01item 9.01
Biomerica appoints former LabCorp Diagnostics CEO Gary Huff to board; director Emerson not standing for re-election
Gary Huff appointed as independent director effective Oct 7, 2025; will serve on Audit, Comp, and Governance committees.
-
Jun 06, 2025 23:59 UTC
leadership
materiality 0.50
neutral
item 5.02item 7.01item 9.01
Biomerica appoints Eric Chin to board; Cathy Coste resigns effective June 4
Cathy Coste resigned as director effective June 4, 2025; no disagreement with the company.
Executive changes
- Effective
- 2025-06-04
- Filed
- Jun 06, 2025 23:59 UTC
On the same date, the Board appointed Mr. Eric Chin to serve as an independent member of the Board, effective immediately
Departed
Cathy Coste
Director
- Effective
- 2025-06-04
- Successor
- Eric Chin
- Filed
- Jun 06, 2025 23:59 UTC
Effective June 4, 2025, Ms. Cathy Coste stepped down as a member of the Board of Directors
Materiality & sentiment trend
Max materiality 0.55
· Median 0.50
· Most common event leadership
1 positive
0 negative
2 neutral
source · BMRA on sec.gov